Twist Bioscience Corporation Announces Pricing of Initial Public Offering
October 30, 2018
SAN FRANCISCO--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA, today announced that it has priced its initial public offering of 5,000,000 shares of its common stock at a price to the public of $14.00 per share, before underwriting discounts and commissions. All of the shares of common stock are [...]
XCR Diagnostics and Luminex Enter into License Agreement
October 30, 2018
SALT LAKE CITY--Privately held XCR Diagnostics Inc. and Luminex Corporation (Nasdaq:LMNX) have entered into a non-exclusive, worldwide license agreement for XCR's proprietary Xtreme Chain Reaction nucleic acid amplification technology. The XCR technology enables extremely rapid thermal cycling protocols to achieve dramatically reduced assay turnaround times compared to traditional polymerase chain reaction. Financial terms were not disclosed. “XCR [...]
eMolecules strengthens and re-structures its Board through the appointment of two new members
October 30, 2018
SAN DIEGO -- eMolecules is pleased to announce the addition of two new members to the Board of Directors: Manuel Brocke-Benz and Max Carnecchia. The Board, strengthened by the arrival of Max and Manuel, provides strategic leadership for eMolecules. Max and Manuel will bring the experience and strategic focus required to drive eMolecules forward in its vision to simplify the search, find [...]
Rheonix Announces Launch of NGS OnePrep™ Automated DNA Extraction and Library Preparation Solution
October 30, 2018
ITHACA, N.Y.---Rheonix, Inc. announces the launch of its NGS OnePrep™ solution, an integrated, automated method for DNA extraction and next-generation sequencing (NGS) library preparation on the Encompass Optimum™ workstation, at the Association of Molecular Pathology (AMP) Annual Meeting and Expo Nov.1-3 in San Antonio, Texas. The method will allow laboratory technicians to produce sequence-ready libraries [...]
Poietis launches its new 4D Bioprinting systems
October 30, 2018
Poietis, the first 4D bioprinting company, announces the commercialization of its new range of NGB systems («Next Generation Bioprinting») to cover all the tissue engineering needs, from research to clinical batches production. Pessac, FRANCE For more than four years, Poietis has been invested in the development of the NGB 4D bioprinting platform to meet the [...]
October 30, 2018
HERCULES, Calif. -- A recent study published online in the Journal of Molecular Diagnostics demonstrated that Droplet Digital PCR (ddPCR) technology can be used to detect mutations in a region of our DNA that is linked to many cancer types, paving the way for the development of new cancer diagnostics and therapies. Two mutations in the promoter region of [...]
Introducing Element-D, the Latest Addition to the Elemental Machines Platform
October 30, 2018
CAMBRIDGE, Mass.--Elemental Machines, a provider of data science and Internet of Things (IoT) solutions for technology-based industries, today announces Element-D, the newest addition to its platform. Element-D (Data) is an IoT data collection device that connects OEM instruments to the cloud to automate the collection of scientific data, metadata such as maintenance and calibration records, and [...]
October 30, 2018
NEW YORK and SHANGHAI - Schrödinger, a privately-held company revolutionizing drug discovery through advanced computational methods and enterprise software solutions, and WuXi AppTec, a leading pharmaceutical and medical device R&D enabling platform company, announced today that they have formed Faxian Therapeutics. The new venture will leverage the precision molecular design platforms developed by Schrödinger and [...]
Co-Diagnostics, Inc. and LGC, Biosearch Technologies Sign License Agreement for CoPrimer Technology
October 30, 2018
Co-Diagnostics agrees to license CoPrimers™ for use in agricultural applications SALT LAKE CITY--Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, proprietary platform for the development of molecular diagnostic tests, and LGC, Biosearch Technologies, a global leader in the design, development, and manufacture of sophisticated, custom oligonucleotide-based tools and associated reagents for applied markets, announced [...]
October 29, 2018
BOLOGNA, Italy and HUNTINGDON VALLEY, Pa. -- Menarini-Silicon Biosystems announced today that it will launch the DEPArray™ FFPE SamplePrep Kit at the upcoming annual meeting of the Association of Molecular Pathology. The DEPArray SamplePrep Kit is the first commercially available kit for the disaggregation and staining of FFPE (formalin-fixed, paraffin-embedded) tissue sections down to a single-cell suspension. The kit enables the detection, identification, [...]

